Both GLP-1-based therapy and bariatric surgery are effective in inducing substantial weight loss. However, these interventions are accompanied by a lesser-discussed but critical consequence: the loss of fat-free mass (FFM), particularly skeletal muscle mass (SMM). Recent reviews indicate that up to 40% of the total weight loss with GLP-1 receptor agonists (RA) comes from FFM, even though fat mass reduction is the primary aim.

This muscle loss is not just cosmetic; it is metabolically and functionally significant, potentially leading to reduced resting energy expenditure, sarcopenia, and compromised long-term weight maintenance.

Protein Intake Remains Suboptimal in Practice

Despite guideline recommendations of ≥60 g/day or 1.0–1.5 g/kg ideal body weight: 

• Up to 87% of bariatric patients fail to meet this target in the first 6 months post-op. 

• Even 3 years after surgery, over 50% still do not achieve adequate intake, despite structured follow-up. 

• In GLP-1 users, early satiety, nausea, and aversion to protein-rich foods further lower intake, particularly of high-quality proteins like meat, dairy, and legumes. 

Less than 20% of patients—GLP-1 or bariatric—achieve sufficient protein intake from food alone, even with dietitian support. 

Protein and Weight Management 

Protein plays a crucial role not only in preserving muscle mass, but also in supporting long-term weight maintenance. This was clearly demonstrated in the Swedish Obesity Subjects study, where Kanerva and colleagues followed over 1600 patients for 10 years after bariatric surgery.

They found that patients who, in the first 6 months after surgery, consumed a relatively higher percentage of their energy from protein and less from fat or carbohydrates maintained significantly more weight loss over time. These findings underline that it’s not just about how much patients eat, but also what the macronutrient composition looks like.

Early emphasis on adequate protein intake may have a lasting impact, both after bariatric surgery and during GLP-1-based therapy. 

Clinical Implications 

For patients undergoing pharmacological or surgical weight loss, preserving muscle mass is not optional—it is critical to long-term health and function. 

Key recommendations: 

• Start protein supplementation early, especially if patients report reduced appetite or food aversion. 

• Aim for 1.2–1.5 g protein/kg ideal body weight/day, adjusted to clinical condition. 

• Combine with resistance training where feasible. 

• Choose supplements with complete amino acid profiles, prioritizing whey or leucine-enriched formulations. 

Would you like to learn more about this research study?

Simply contact us using the button below: